S01LA06 brolucizumab
ATC group of level 5 – chemical substance · in plain English: eye medicines
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 prescription only (POM)
Active substance: Brolucizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- S Sensory organ drugs 363 medicines
- S01 Ophthalmologicals 345 medicines
- S01L Ocular vascular disorder agents 29 medicines
- S01LA Antineovascularisation agents 29 medicines
- S01LA06 brolucizumab 2 medicines
- S01LA Antineovascularisation agents 29 medicines
- S01L Ocular vascular disorder agents 29 medicines
- S01 Ophthalmologicals 345 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Beovu 120 mg / ml solution for injection, Beovu 120 mg / ml solution for injection in Pre Filled syringe SPC | Prescription only (POM) |
| Beovu 120 mg/ml solution for injection SPC | Prescription only (POM) |
Other groups of the same level
- S01LA01 verteporfin 1 medicine
- S01LA03 pegaptanib 1 medicine
- S01LA04 ranibizumab 12 medicines
- S01LA05 aflibercept 13 medicines
Other names of the ATC group
- German: S01LA06 Brolucizumab
- Spanish: S01LA06 BROLUCIZUMAB
- German: S01LA06 Brolucizumab
- Italian: S01LA06 BROLUCIZUMAB
- Turkish: S01LA06 brolucizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group S01LA06
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.